283 related articles for article (PubMed ID: 17047057)
1. Signal transducers and activators of transcription 5b activation enhances hepatocellular carcinoma aggressiveness through induction of epithelial-mesenchymal transition.
Lee TK; Man K; Poon RT; Lo CM; Yuen AP; Ng IO; Ng KT; Leonard W; Fan ST
Cancer Res; 2006 Oct; 66(20):9948-56. PubMed ID: 17047057
[TBL] [Abstract][Full Text] [Related]
2. HBx protein induces EMT through c-Src activation in SMMC-7721 hepatoma cell line.
Yang SZ; Zhang LD; Zhang Y; Xiong Y; Zhang YJ; Li HL; Li XW; Dong JH
Biochem Biophys Res Commun; 2009 May; 382(3):555-60. PubMed ID: 19302982
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of nuclear factor-kappaB, urokinase-type plasminogen activator, and HBx and their clinicopathological significance in hepatocellular carcinoma.
Chan CF; Yau TO; Jin DY; Wong CM; Fan ST; Ng IO
Clin Cancer Res; 2004 Jun; 10(12 Pt 1):4140-9. PubMed ID: 15217951
[TBL] [Abstract][Full Text] [Related]
4. Expression of the serum response factor in hepatocellular carcinoma: implications for epithelial-mesenchymal transition.
Park MY; Kim KR; Park HS; Park BH; Choi HN; Jang KY; Chung MJ; Kang MJ; Lee DG; Moon WS
Int J Oncol; 2007 Dec; 31(6):1309-15. PubMed ID: 17982656
[TBL] [Abstract][Full Text] [Related]
5. RNA interference targeting HBx suppresses tumor growth and enhances cisplatin chemosensitivity in human hepatocellular carcinoma.
Cheng AS; Wong N; Tse AM; Chan KY; Chan KK; Sung JJ; Chan HL
Cancer Lett; 2007 Aug; 253(1):43-52. PubMed ID: 17296261
[TBL] [Abstract][Full Text] [Related]
6. Liver-intestine cadherin predicts microvascular invasion and poor prognosis of hepatitis B virus-positive hepatocellular carcinoma.
Ding ZB; Shi YH; Zhou J; Shi GM; Ke AW; Qiu SJ; Wang XY; Dai Z; Xu Y; Fan J
Cancer; 2009 Oct; 115(20):4753-65. PubMed ID: 19626651
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus X protein induced expression of the Nur77 gene.
Lee MO; Kang HJ; Cho H; Shin EC; Park JH; Kim SJ
Biochem Biophys Res Commun; 2001 Nov; 288(5):1162-8. PubMed ID: 11700033
[TBL] [Abstract][Full Text] [Related]
8. Constitutive activation of Stat5b contributes to carcinogenesis in vivo.
Xi S; Zhang Q; Gooding WE; Smithgall TE; Grandis JR
Cancer Res; 2003 Oct; 63(20):6763-71. PubMed ID: 14583472
[TBL] [Abstract][Full Text] [Related]
9. Upregulated FoxM1 expression induced by hepatitis B virus X protein promotes tumor metastasis and indicates poor prognosis in hepatitis B virus-related hepatocellular carcinoma.
Xia L; Huang W; Tian D; Zhu H; Zhang Y; Hu H; Fan D; Nie Y; Wu K
J Hepatol; 2012 Sep; 57(3):600-12. PubMed ID: 22613004
[TBL] [Abstract][Full Text] [Related]
10. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Deng X; Zhao XF; Liang XQ; Chen R; Pan YF; Liang J
Biomed Pharmacother; 2017 Jun; 90():100-108. PubMed ID: 28343069
[TBL] [Abstract][Full Text] [Related]
11. ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma.
Lin SY; Pan HW; Liu SH; Jeng YM; Hu FC; Peng SY; Lai PL; Hsu HC
Clin Cancer Res; 2008 Aug; 14(15):4814-20. PubMed ID: 18676753
[TBL] [Abstract][Full Text] [Related]
12. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D
Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760
[TBL] [Abstract][Full Text] [Related]
13. Fascin-1 expression correlates with repression of E-cadherin expression in hepatocellular carcinoma cells and augments their invasiveness in combination with matrix metalloproteinases.
Hayashi Y; Osanai M; Lee GH
Cancer Sci; 2011 Jun; 102(6):1228-35. PubMed ID: 21323792
[TBL] [Abstract][Full Text] [Related]
14. STAT5 isoforms regulate colorectal cancer cell apoptosis via reduction of mitochondrial membrane potential and generation of reactive oxygen species.
Du W; Wang YC; Hong J; Su WY; Lin YW; Lu R; Xiong H; Fang JY
J Cell Physiol; 2012 Jun; 227(6):2421-9. PubMed ID: 21826656
[TBL] [Abstract][Full Text] [Related]
15. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
[TBL] [Abstract][Full Text] [Related]
16. Expression of B7-H4 and hepatitis B virus X in hepatitis B virus-related hepatocellular carcinoma.
Hong B; Qian Y; Zhang H; Sang YW; Cheng LF; Wang Q; Gao S; Zheng M; Yao HP
World J Gastroenterol; 2016 May; 22(18):4538-46. PubMed ID: 27182163
[TBL] [Abstract][Full Text] [Related]
17. Activation of beta-catenin by hypoxia in hepatocellular carcinoma contributes to enhanced metastatic potential and poor prognosis.
Liu L; Zhu XD; Wang WQ; Shen Y; Qin Y; Ren ZG; Sun HC; Tang ZY
Clin Cancer Res; 2010 May; 16(10):2740-50. PubMed ID: 20460486
[TBL] [Abstract][Full Text] [Related]
18. Differential function of STAT5 isoforms in head and neck cancer growth control.
Leong PL; Xi S; Drenning SD; Dyer KF; Wentzel AL; Lerner EC; Smithgall TE; Grandis JR
Oncogene; 2002 Apr; 21(18):2846-53. PubMed ID: 11973644
[TBL] [Abstract][Full Text] [Related]
19. Characteristics and prognosis of patients in Japan with viral marker-negative hepatocellular carcinoma.
Toyoda H; Kumada T; Kiriyama S; Sone Y; Tanikawa M; Hisanaga Y; Kanamori A; Yamaguchi A; Isogai M; Kaneoka Y; Washizu J
J Gastroenterol Hepatol; 2008 Mar; 23(3):459-66. PubMed ID: 17854425
[TBL] [Abstract][Full Text] [Related]
20. Sequential accumulation of the mutations in core promoter of hepatitis B virus is associated with the development of hepatocellular carcinoma in Qidong, China.
Guo X; Jin Y; Qian G; Tu H
J Hepatol; 2008 Nov; 49(5):718-25. PubMed ID: 18801591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]